HBOT for Traumatic Brain Injury: Mechanisms, Protocols, and What the Research Shows

Hyperbaric oxygen therapy (HBOT) for traumatic brain injury (TBI) means breathing 100% oxygen in a pressurized chamber at 1.5 to 2.0 ATA, usually for 40 to 60 daily sessions, and its best evidence is for mild TBI with post-concussion symptoms that persist for months or years. Randomized trials at 1.5 ATA reported gains in memory, attention and symptoms, but sham-controlled military trials found smaller or no differences, and the FDA has not cleared HBOT for TBI.

Hyperbaric oxygen therapy for traumatic brain injury sits at an interesting intersection: strong biological rationale, compelling smaller trial data, an ongoing debate in the literature about optimal pressure and patient selection, and a patient population, particularly military veterans, for whom existing treatments are often inadequate.

The FDA has not approved HBOT specifically for TBI, meaning its use for this indication is off-label. The FDA has cleared hyperbaric chambers for 13 conditions, such as decompression sickness and carbon monoxide poisoning, and brain injury is not one of them. Off-label status reflects an incomplete regulatory pathway rather than a verdict either way. The evidence base is sufficient to support serious clinical consideration, particularly for persistent post-concussion syndrome that has not responded to standard care, as the hyperbaric oxygen therapy treatment guide explains.

Why TBI Creates Lasting Damage

The initial injury in TBI causes direct mechanical damage and triggers a secondary injury cascade: neuroinflammation, glutamate excitotoxicity, mitochondrial dysfunction, and disruption of cerebral autoregulation. Cells in the “penumbra” around the injury site are not dead but are metabolically compromised, receiving inadequate oxygen and glucose to function normally.

In mild TBI and persistent post-concussion syndrome, diffuse axonal injury and microglial activation can continue for months to years after the initial impact. This is what drives ongoing symptoms: headaches, cognitive slowing, irritability, sleep disruption, and depression. Standard neuroimaging (MRI, CT) often looks normal in these patients, even when they are substantially impaired.

Clinicians use overlapping terms for this picture: mild TBI (mTBI), concussion, post-concussion syndrome (PCS) and persistent postconcussive symptoms. The overview of traumatic brain injury as a condition covers how severity is graded, and the post-concussion syndrome explainer covers the lingering symptoms that bring most people to HBOT.

How HBOT Works in TBI

Oxygen Delivery and the Penumbra

Breathing 100% oxygen at 2.0 ATA raises the oxygen dissolved in plasma from roughly 0.3 mL per 100 mL of blood on room air to more than 4 mL per 100 mL, independent of hemoglobin. This dramatically increases oxygen delivery to metabolically stressed tissue, particularly in watershed zones and areas with marginal perfusion. Compromised neurons that are “idling” rather than dead may resume normal function when oxygen availability increases.

Neuroplasticity and Angiogenesis

Repeated cycles of hyperoxia and return to normal oxygen levels appear to trigger adaptive responses that go beyond simple oxygenation. HBOT increases VEGF (vascular endothelial growth factor) expression, promoting angiogenesis in ischemic tissue. It also upregulates BDNF (brain-derived neurotrophic factor) and promotes synaptogenesis, the formation of new synaptic connections.

A 2017 study in Frontiers in Human Neuroscience (Tal et al.) used perfusion MRI and diffusion tensor imaging in 15 patients with prolonged post-concussion syndrome who completed 60 HBOT sessions. Cerebral blood flow and white matter measures improved alongside memory, executive function and processing speed. The study had no control group, so it shows what changed, not how much HBOT itself caused.

Neuroinflammation Reduction

HBOT has anti-inflammatory effects mediated through inhibition of NF-kB, reduction of microglial activation, and decreased expression of pro-inflammatory cytokines including IL-1beta, TNF-alpha, and IL-6. In the TBI context, chronic microglial activation is a driver of ongoing symptoms, and blunting this inflammatory state may be part of how HBOT produces lasting improvements. Much of this mechanistic work comes from animal models.

Clinical Evidence

HBOT for TBI has been tested in a small number of randomized trials, nearly all in mild TBI and each with fewer than 75 participants. Trials comparing HBOT with no treatment reported clear gains, while US military trials comparing HBOT with a sham chamber found that both groups improved.

The Israeli SPECT Studies

Some of the most cited HBOT-TBI research comes from the team led by Dr. Shai Efrati at Tel Aviv University and the Sagol Center for Hyperbaric Medicine. Their work has used SPECT (single photon emission computed tomography) brain imaging to document both pre-treatment hypoperfusion patterns and post-treatment changes.

A pivotal 2013 RCT (Boussi-Gross et al., n=56) enrolled TBI patients with persistent symptoms 1 to 5 years post-injury and randomized them to 40 sessions of HBOT at 1.5 ATA or a no-treatment control period followed by crossover. HBOT patients showed significant improvement in cognitive function (memory, attention, executive function) and quality of life measures. SPECT imaging demonstrated increased brain activity in regions that had been hypoperfused at baseline.

A 2018 retrospective analysis by the same group (Hadanny et al., n=154) extended this work to mild, moderate and severe TBI, again finding significant neuropsychological improvement, though without a control group. Critics have noted methodological concerns, particularly around blinding (patients know if they are receiving hyperbaric oxygen versus no treatment), but the consistency of findings across multiple studies is meaningful.

Mild TBI and Post-Concussion Syndrome

The BIMA trial (Weaver et al., 2018, n=71) examined military personnel with mild TBI and persistent post-concussion symptoms. Participants received 40 sessions of HBOT at 1.5 ATA or sham (room air in a chamber at 1.2 ATA). The HBOT group showed better outcomes on the Rivermead Post Concussion Symptoms Questionnaire and some cognitive measures at 13 weeks, with larger effects in participants who also had PTSD, but most gains regressed by 12 months.

The earlier HOPPS trial (Miller et al., 2015, n=72) found that HBOT and sham groups both improved more than routine care alone, with no meaningful difference between them. In a civilian and veteran population, Harch et al. (2020) reported improvements in symptoms, memory, processing speed and mood after 40 sessions at 1.5 ATA compared with a no-treatment period.

The sham pressure of 1.2 ATA used in this and other trials has been criticized: some researchers believe that 1.2 ATA with room air may itself have a mild therapeutic effect (slight oxygen increase), potentially compressing the apparent difference between active treatment and control. This is an ongoing methodological debate.

A 2022 systematic review in Frontiers in Neurology (Harch) concluded that 40 sessions at 1.5 ATA produced significant improvements in four randomized trials, while one trial at 2.4 ATA (Wolf et al., 2012) was negative. The review author is also a leading HBOT clinician, so larger independent trials remain the missing piece.

Moderate to Severe TBI

Evidence for moderate-to-severe TBI is thinner, and results are more mixed. A Cochrane review (Bennett et al., 2012) pooled seven trials with 571 people treated soon after injury and found that HBOT may reduce the risk of death and improve Glasgow Coma Scale scores, but there was little evidence that survivors had a good functional outcome, so routine use could not be justified. Severe TBI may involve structural damage beyond what hyperoxygenation can meaningfully address.

Military and VA Research

TBI is the signature injury of the post-9/11 conflicts, affecting an estimated 400,000 veterans. The Veterans Administration and Department of Defense have invested significantly in HBOT research, partly in response to strong patient and advocacy demand.

The Department of Defense sponsored four randomized trials: an Air Force study (Wolf et al., 2012), a Navy study at Naval Air Station Pensacola (Cifu et al., 2014), and the multi-site HOPPS and BIMA trials. They produced mixed results, with some analyses showing benefit and others not reaching significance, contributing to ongoing uncertainty in the field. These trials used different pressure protocols and populations, making direct comparison difficult.

As of 2024, the VA does not routinely cover HBOT for TBI, though some individual VA medical centers offer it through research protocols. This is a significant access barrier for veterans who might benefit, many of whom seek treatment at private hyperbaric centers at personal expense. Many also live with PTSD, which the PTSD treatment guide covers.

Who Is a Candidate for HBOT After a Brain Injury?

The patients who most resemble those in the positive trials are adults with mild TBI or concussion whose symptoms have lasted several months or longer despite standard care. Participants in Boussi-Gross et al. (2013) were 1 to 5 years past their injury, so a long gap does not by itself rule someone out.

A hyperbaric physician screens for conditions that make pressurization unsafe or need management first:

• An untreated pneumothorax (collapsed lung) is the main absolute contraindication.
• Some chemotherapy drugs, a seizure disorder or a high fever raise the risk of oxygen toxicity.
• Severe COPD, recent ear surgery and implanted devices not rated for pressure need individual review.

For moderate or severe TBI, HBOT is usually discussed as one part of a broader traumatic brain injury treatment plan that includes neurologists, physiatrists, neuropsychologists and rehabilitation therapists.

Treatment Protocols

Most HBOT-TBI research has used 1.5 ATA rather than the higher 2.0 to 2.4 ATA used for wound healing and decompression sickness. The reasoning is that TBI pathophysiology (neuroinflammation, ischemic penumbra) responds to lower pressures, and higher pressures carry greater risk of oxygen toxicity with longer courses.

Two named protocols dominate private practice: the Harch protocol of 40 sessions at 1.5 ATA, which matches the randomized trials, and the Efrati protocol of about 60 sessions at 2.0 ATA with cognitive testing before and after. The Efrati versus Harch protocol comparison sets out the differences.

What to Expect During an HBOT Course for TBI

An HBOT course for TBI takes 8 to 12 weeks of near-daily visits. It usually follows these steps:

1. An intake visit with a hyperbaric physician reviews the injury, medications and contraindications.
2. Baseline testing records a cognitive battery and a symptom questionnaire, sometimes with SPECT or perfusion MRI.
3. Each session starts with slow compression while you equalize your ears, then 60 to 90 minutes of 100% oxygen.
4. Repeat testing around session 40 guides the decision to stop or extend.

Safety and Side Effects

HBOT is generally well-tolerated. The most common side effect is ear barotrauma from pressure changes, presenting as ear discomfort or muffled hearing. This is prevented by equalizing pressure during compression (like during a flight descent) and resolves quickly. Myopia (nearsightedness) can develop with prolonged courses and is usually reversible after treatment ends.

In the Air Force TBI trial, Wolf et al. (2012) recorded ear block in about 5.9% of HBOT exposures at 2.4 ATA and no seizures or other major adverse events.

Oxygen toxicity seizures are rare at the pressures used for TBI protocols (1.5 to 2.0 ATA) but are a risk at higher pressures. They typically stop once oxygen is removed and are not known to cause lasting harm when they occur in a clinical setting. Risk is estimated at less than 1 per 10,000 sessions at 2.0 ATA.

Claustrophobia is relevant for monoplace chambers (individual pressurized tubes) and less so for multiplace chambers (rooms that pressurize multiple patients simultaneously). Facilities typically screen for claustrophobia before treatment and offer acclimation sessions if needed.

Cost and Access

Medical-grade HBOT at a hyperbaric center costs $150 to $400 per session. A 40-session protocol therefore costs $6,000 to $16,000; 60-session courses reach $9,000 to $24,000. These are substantial out-of-pocket costs given the lack of insurance coverage for TBI indications.

Some non-profit organizations provide subsidized HBOT to veterans, including the Harch Hyperbaric Research Foundation and various veteran-focused clinics. The Wounded Warriors Project has funded HBOT research and treatment programs at select facilities.

For patients with traumatic brain injury who are considering HBOT, the key questions to ask a hyperbaric center are: What pressure protocol do you use for TBI? Do you have a physician who specializes in hyperbaric medicine, not just a technician-run program? Do you do pre- and post-treatment cognitive assessment to track progress? A quality center should answer all of these confidently.

Mild hyperbaric devices sold for home use (typically 1.3 ATA) are different from medical-grade equipment. They do not reach therapeutic pressures for TBI and should not be equated with clinical HBOT. The research on TBI has used 1.5 to 2.0 ATA in medical settings, and that is what matters for evaluating the evidence.

Regenerated.com lists hyperbaric oxygen therapy clinics across the US and is free for patients. Listing order is not paid ranking, Featured slots are labeled and capped, and Verified means credential checks, not spend. Inclusion is not an endorsement, so ask any center the questions above.

Frequently asked questions

Does hyperbaric oxygen therapy work for traumatic brain injury?

HBOT has the most support for mild TBI with post-concussion symptoms lasting months or years. Randomized trials at 1.5 ATA by Boussi-Gross et al. (2013) and Harch et al. (2020) reported better memory, attention and symptom scores than no treatment. Sham-controlled military trials such as HOPPS found that sham chambers produced similar gains, so the true size of the oxygen effect is still uncertain.

How many HBOT sessions are needed for a brain injury?

Most TBI protocols use 40 to 60 sessions of 60 to 90 minutes each, given 5 days per week over 8 to 12 weeks. The randomized trials in mild TBI almost all used 40 sessions at 1.5 ATA, while the Efrati protocol commonly uses 60 sessions at 2.0 ATA. Many centers retest cognition around session 40 before extending.

Is HBOT FDA approved for TBI or concussion?

No. The FDA has cleared hyperbaric chambers for 13 conditions, including decompression sickness, carbon monoxide poisoning and diabetic foot ulcers, and traumatic brain injury is not on that list. Physicians can still prescribe HBOT for TBI off label, but insurers and the VA generally do not pay for it, so most patients cover the cost themselves.

How much does HBOT for TBI cost?

Medical hyperbaric centers charge about $150 to $400 per session, so a 40-session TBI course runs about $6,000 to $16,000 and a 60-session course about $9,000 to $24,000. Insurance rarely covers HBOT for brain injury because the use is off label. Some veterans receive subsidized treatment through non-profit programs or VA research protocols.

Can HBOT help years after a concussion?

Several studies enrolled people long after their injury and still reported gains. Boussi-Gross et al. (2013) treated adults 1 to 5 years after mild TBI, and Tal et al. (2017) reported imaging and cognitive changes about a decade after injury on average. Most of these studies lacked sham controls, so they support a measured trial of treatment rather than a predictable response.